To date, studies using viral vector gene therapy in the Fmr1 KO mouse model of FXS have employed AAV5 and AAV9 vectors and the coding sequence of the full-length Fmr1 isoform 1. The gene discussed is FMR1; the disease is fragile X syndrome.